Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicines Australia Makes $100,000 Donation To Bushfire Appeal Fund; Praises Govt Advisory Structure

This article was originally published in PharmAsia News

Executive Summary

PERTH, Australia - Medicines Australia made a cash contribution Feb. 9 of $100,000 to the 2009 Victorian Bushfire Appeal Fund to support those affected by the weekend's bushfires in the Australian State of Victoria

You may also be interested in...



Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy

PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry

Australian Biotech Faces Perfect Storm

PERTH, Australia - Investment in Australia's biotech sector plummeted to AU$183 million in 2008, down from AU$ 943 million in 2007, AusBiotech reported

AusBiotech Chief Executive Anna Lavelle On Biotech’s Role In Asia Pacific: An Interview with PharmAsia News (Part 1 of 2)

PERTH, Australia - AusBiotech is Australia's Biotechnology Industry Organization, which represents over 2,400 members, covering the human health, agricultural, medical device, bioinformatics, environmental and industrial sectors in biotechnology. AusBiotech has representation in each Australian state providing a national network to support members and promote the commercialization of Australian bioscience in the national and international marketplaces. AusBiotech Chief Executive Dr. Anna Lavelle recently talked with PharmAsia News' Australian bureau about the role of the Australian biotech sector in Australia and globally.

Related Content

UsernamePublicRestriction

Register

SC070984

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel